Engitix

About Engitix

Engitix is a biotechnology company that uses its extracellular matrix (ECM) platform to model disease biology and discover new drug targets, biomarkers, and therapies for fibrosis, inflammation, and solid tumors. The company focuses on tissue-specific human ECM scaffolds to study disease mechanisms and identify disease-specific ECM changes that influence clinical outcomes. It aims to form collaborations with pharma and biotech to expand the discovery potential across fibrotic and cancer indications and related chronic diseases, with operations centered in London, United Kingdom.